These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18235041)

  • 1. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.
    Rezaei N; Aghamohammadi A; Siadat SD; Moin M; Pourpak Z; Nejati M; Ahmadi H; Kamali S; Norouzian D; Tabaraei B; Read RC
    Clin Vaccine Immunol; 2008 Apr; 15(4):607-11. PubMed ID: 18235041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency.
    Rezaei N; Siadat SD; Aghamohammadi A; Moin M; Pourpak Z; Norouzian D; Mobarakeh JI; Aghasadeghi MR; Nejati M; Read RC
    Clin Vaccine Immunol; 2010 Apr; 17(4):524-8. PubMed ID: 20106999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to polysaccharide vaccination amongst pediatric patients with common variable immunodeficiency correlates with clinical disease.
    Rezaei N; Aghamohammadi A; Read RC
    Iran J Allergy Asthma Immunol; 2008 Dec; 7(4):231-4. PubMed ID: 19052353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.
    Rezaei N; Aghamohammadi A; Siadat SD; Nejati M; Ahmadi H; Moin M; Pourpak Z; Kamali S; Norouzian D; Tabaraei B; Read RC
    Vaccine; 2007 Jul; 25(29):5308-14. PubMed ID: 17574314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.
    Rezaei N; Haji-Molla-Hoseini M; Aghamohammadi A; Pourfathollah AA; Moghtadaie M; Pourpak Z
    J Clin Immunol; 2008 Jan; 28(1):78-84. PubMed ID: 17912490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications.
    Vodjgani M; Aghamohammadi A; Samadi M; Moin M; Hadjati J; Mirahmadian M; Parvaneh N; Salavati A; Abdollahzade S; Rezaei N; Srrafnejad A
    J Investig Allergol Clin Immunol; 2007; 17(5):321-8. PubMed ID: 17982925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.
    Borrow R; Andrews N; Goldblatt D; Miller E
    Infect Immun; 2001 Mar; 69(3):1568-73. PubMed ID: 11179328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production by activated T cells in common variable immunodeficiency.
    Rezaei N; Aghamohammadi A; Nourizadeh M; Kardar GA; Pourpak Z; Zare A; Read RC
    J Investig Allergol Clin Immunol; 2010; 20(3):244-51. PubMed ID: 20635790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.
    Andrews N; Borrow R; Miller E
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):780-6. PubMed ID: 12965904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.
    Idoko OT; Okolo SN; Plikaytis B; Akinsola A; Viviani S; Borrow R; Carlone G; Findlow H; Elie C; Kulkarni PS; Preziosi MP; Ota M; Kampmann B
    Vaccine; 2014 Jul; 32(33):4220-7. PubMed ID: 24863486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets.
    Yazdani R; Seify R; Ganjalikhani-Hakemi M; Abolhassani H; Eskandari N; Golsaz-Shirazi F; Ansaripour B; Salehi E; Azizi G; Rezaei N; Aghamohammadi A
    Allergol Immunopathol (Madr); 2017; 45(2):183-192. PubMed ID: 27717724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.
    Brodszki N; Skattum L; Bai X; Findlow H; Borrow R; Jönsson G
    Vaccine; 2015 Apr; 33(15):1839-45. PubMed ID: 25707694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active vaccination in patients with common variable immunodeficiency (CVID).
    Goldacker S; Draeger R; Warnatz K; Huzly D; Salzer U; Thiel J; Eibel H; Schlesier M; Peter HH
    Clin Immunol; 2007 Sep; 124(3):294-303. PubMed ID: 17602874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
    Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
    J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG; Löbel M; Mieves JF; Bauer S; Babel N; Schweiger B; Wittke K; Grabowski P; Volk HD; Scheibenbogen C
    Vaccine; 2016 May; 34(21):2417-2423. PubMed ID: 27055021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunological features of common variable immunodeficiency in Mexican patients.
    Ramírez-Vargas N; Arablin-Oropeza SE; Mojica-Martínez D; Yamazaki-Nakashimada MA; de la Luz García-Cruz M; Terán-Juárez LM; Cortés-Grimaldo RM; Torres-Lozano C; Madrigal-Beas I; Ortega-Cisneros M; Vargas-Camaño ME; Staines-Boone T; Pietropaolo-Cienfuegos D; Berrón-Ruiz L; Espinosa-Rosales FJ; Guevara-Cruz M; Blancas-Galicia L
    Allergol Immunopathol (Madr); 2014; 42(3):235-40. PubMed ID: 23578780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.
    Jokhdar H; Borrow R; Sultan A; Adi M; Riley C; Fuller E; Baxter D
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):83-8. PubMed ID: 14715549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical and immunological features and mortality in common variable immunodeficiency and agammaglobulinemia patients.
    Bagheri Y; Vosughi A; Azizi G; Yazdani R; Kiaee F; Hafezi N; Alimorad S; Khoshmirsafa M; Seif F; Hassanpour G; Abolhassani H; Aghamohammadi A
    Immunol Lett; 2019 Jun; 210():55-62. PubMed ID: 31059734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications.
    Aydogan M; Eifan AO; Gocmen I; Ozdemir C; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2008; 18(4):260-5. PubMed ID: 18714533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.